Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
akcea therapeutics
alnylam pharmaceuticals
andrew fire
author_name|malak saleh
boston
boston blog main
boston top stories
clinical trials
craig mello
disease & medical conditions
fda
health
health care industry
hereditary transthyretin amyloidosis
inotersen
john maraganore
language|en-us
life sciences
national blog main
national top stories
new york blog main
new york top stories
nobel prize
onpattro
patisiran
pfizer
provider_name|engadget
region|us
rna interference
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
site|engadget
tafamidis
tests & procedures
vyndaqel
What
fda
gets
2
×
ok
2
×
afternoon
alnylam
alnylam’s
approval
approved
arm
atrial
biosense
cause
condition
developed
drug
failure
fibrillation
heart
heartbeat
history
irregular
j
johnson
landmark
make
makes
making
medical
medicine
medtech
new
onpattro
patisiran
pharmaceuticals
products
professionals
rays
received
require
rnai
Language
unset
Current search:
ok
×
gets
×
@engadget.com
9 months ago
Johnson & Johnson gets FDA approval for heart treatments that don't require X-rays
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
